GRI BIO, Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Jan-11-19	Jan-11-18
	10-K	10-K	10-K	10-K	S-1/A	S-1/A
Revenues	0.0	-0.1	0.1	1.9	1.9	3.5
Revenue growth	-100.0%	-189.0%	-94.7%	0.0%	-46.4%
Cost of goods sold	0.0	-18.5	0.0	3.2	3.2	4.3
Gross profit	0.0	18.4	0.1	-1.3	-1.3	-0.8
Gross margin		-20706.7%	100.0%	-67.6%	-67.6%	-22.8%
Selling, general and administrative [+]	5.8	4.1	1.2	1.3	1.3	0.8
General and administrative	5.8	4.1	1.2	1.3	1.3	0.8
Research and development	1.2	5.2	3.7
Other operating expenses		18.4		0.6	0.6	2.7
EBITDA [+]				-3.2
EBITDA growth	-25.2%	93.4%	51.9%	0.0%	-26.9%
EBITDA margin		10403.4%	-4788.0%	-167.5%	-167.6%	-122.8%
Depreciation and amortization				0.0
EBIT [+]	-6.9	-9.3	-4.8	-3.2	-3.2	-4.3
EBIT growth	-25.2%	93.4%	51.8%	0.0%	-26.9%
EBIT margin		10403.4%	-4788.0%	-167.6%	-167.6%	-122.8%
Interest expense, net [+]	0.0	0.0	0.0	0.2	0.2	0.0
Interest expense		0.0	0.0	0.2	0.2
Interest income	0.0					0.0
Other income (expense), net [+]	-0.1	0.0		-0.1	-0.1
Unrealized gain/loss on derivatives	0.4			-0.1
Change in fair value of warrants	0.4
Other		0.1
Pre-tax income	-7.0	-9.3	-4.8	-3.5	-3.5	-4.3
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-7.0	-9.3	-4.8	-3.5	-3.5	-4.3
Net margin		10452.8%	-4822.0%	-184.1%	-184.1%	-122.8%

Basic EPS [+]	($0.69)	($1.42)	($1.07)	($0.98)
Growth	-51.3%	32.9%	9.7%
Diluted EPS [+]	($0.69)	($1.42)	($1.07)	($0.98)
Growth	-51.3%	32.9%	9.7%

Shares outstanding (basic) [+]	10.1	6.5	4.5	3.6
Growth	55.1%	45.2%	26.9%
Shares outstanding (diluted) [+]	10.1	6.5	4.5	3.6
Growth	55.1%	45.2%	26.9%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.